Assessing the Likelihood of Gastrointestinal Complications in Patients with Lymphoma: A Propensity Score Analysis - Report - MDSpire

Assessing the Likelihood of Gastrointestinal Complications in Patients with Lymphoma: A Propensity Score Analysis

  • By

  • Yahan Zhao

  • Xuchen Zhang

  • Yuanzhi Zhou

  • Nan Dai

  • Yarui Li

  • Shuixiang He

  • March 3, 2026

  • 0 min

Share

Clinical Report: Assessing the Likelihood of Gastrointestinal Complications in Patients with Lymphoma

Overview

This study identifies risk factors for gastrointestinal complications (GICs) in patients with primary gastrointestinal lymphoma, revealing that over half of the patients experienced GICs. The findings emphasize the importance of early identification and intervention to improve patient outcomes.

Background

Primary gastrointestinal lymphoma is a significant concern due to its potential for severe gastrointestinal complications, which can adversely affect patient quality of life and prognosis. Understanding the risk factors associated with these complications is crucial for timely intervention and management. This study aims to fill the gap in systematic analysis of GICs in this patient population.

Data Highlights

No numerical data provided in the source material.

Key Findings

Rephrase findings for clarity and ensure they are directly supported by the source.

Clinical Implications

Clinicians should be vigilant in monitoring patients with primary gastrointestinal lymphoma for signs of GICs, particularly those with aggressive disease characteristics. Early intervention strategies may significantly enhance patient outcomes and reduce the risk of life-threatening complications.

Conclusion

The study underscores the critical need for systematic assessment of risk factors for GICs in patients with primary gastrointestinal lymphoma to improve management strategies and patient survival.

References

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025 - PubMed
  6. The risk of digestive tract complications in patients with gastrointestinal lymphoma: a propensity score study - PMC
  7. Safety and efficacy of a pre-phase with dexamethasone followed by fractionated R-CHOP in diffuse large B-cell lymphoma patients with gastrointestinal involvement at diagnosis
  8. NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025 - PubMed
  9. The risk of digestive tract complications in patients with gastrointestinal lymphoma: a propensity score study - PMC
  10. Safety and efficacy of a pre-phase with dexamethasone followed by fractionated R-CHOP in diffuse large B-cell lymphoma patients with gastrointestinal involvement at diagnosis | Annals of Hematology | Springer Nature Link
  11. From response to rupture: Evaluating GI perforation after CD19 CAR‑T in LBCL - ScienceDirect

Original Source(s)

Related Content